What's Driving Roche's $5.7 Billion Bid for Illumina

Roche’s $5.7 billion hostile bid for the sequencing company Illumina could create a personalized medicine powerhouse capable of not only driving a transformation in the treatment of disease, but its diagnosis as well. Roche has big ...

Big Biotech Fuels M&A Activity

Amgen and Celgene acquisitions add to growing list of biotech buys. Big Biotech is muscling into an arena long dominated by Big Pharma, acquiring biotech companies to address pipeline issues or cement a leading position in a therapeutic ...

Gates Gives Global Fund $750 Million Boost

Philanthropist says tough economic times are no excuse for cutting aid to the world’s poorest.The Global Fund to Fight AIDS, Tuberculosis and Malaria has received a major financial boost with a $750 million promissory note from the Bill ...

New fluorescent dyes highlight neuronal activity

Researchers at the University of California, San Diego School of Medicine have created a new generation of fast-acting fluorescent dyes that optically highlight electrical activity in neuronal membranes. The work is published in this week's online Early Edition of the Proceedings of the National Academy of Sciences....

Study reveals enzyme function, could help find muscular dystrophy therapies

Study reveals function of glycosylating enzyme involved in muscular dystrophy, brain development and infection by arenaviruses such as Lassa fever; ability to assay enzyme activity could help screen potential muscular dystrophy therapies Researchers at the University of Iowa have worked out the exact function of an enzyme that is critical for normal muscle structure and is involved in several muscular dystrophies. The findings, which were published Jan. 6 in the journal Science, could be used to develop rapid, large-scale testing of potential muscular dystrophy ...

JAMA commentary contends vitamin therapy can still reduce stroke

President's Bioethics Commission releases report on human subjects protection

AZ, GSK ask carmakers for directions amid pharma breakdown

David Berry: Renewable Petroleum from Microbes

David Berry is sitting in a midtown Manhattan coffee shop, taking a break from a carbon-trading conference across the street, when a news report on the wall-mounted television catches his ...

Jeffrey Bode:Peptide "Legos" to Make New Drugs

 The market for protein-based drugs, such as insulin and human growth hormone, has doubled over the last five years, to more than $50 billion. But making therapeutic proteins is difficult. ...

2011 October Highlights

2nd World Pharmacogenomics Summit 2011  October 25-27, 2011 |  Munich, Germany  The 2nd World Pharmacogenomics Summit is the perfect place for individuals focusing on biomarkers, drug safety/efficacy or clinical decision making to discover best practise in ...

2011 September Highlights

HUPO 10th Annual World Congress  September 4-7, 2011 | Geneva, Switzerland  HUPO 10th Annual World Congress, combined with 5th EuPA Annual Scientific Meeting and the 8th SPS scientific meeting, will be held in Geneva, Switzerland. The Scientific Program ...

2011 August Highlights

International Conference & Exhibition on Cancer Science & Therapy  15-17 August 2011 |  Las Vegas, USA OMICS Group invites all the participants across the globe to attend International Conference & Exhibition on Cancer Science & Therapy during 15-17 August 2011 Las ...

Andor Deep-Depletion CCD Camera Captures Advance That Could Speed-Up Introduction Of Stem Cell Therapy

Many medical researchers believe that stem cell therapy will revolutionise the treatment of human disease and may provide treatments for many currently incurable diseases. However, one problem still to be ...

NEW Capnograph For Small Rodents & Respiratory Mechanics

Harvard Apparatus-Hugo Sachs Electronik is proud to introduce the Type 340 Capnograph for small rodents. This extremely low dead space Capnograph makes it suitable for mice as well as other ...

Hyglos Introduces EndoLISA®, The World’s First ELISA-Based Endotoxin Detection Method

Hyglos today has the pleasure to present EndoLISA®, the world’s first commercially available ELISA-based endotoxin detection method. EndoLISA® is the result of several years of research and test development aimed at ...

Why did healthy children fall critically ill in the 2009 H1N1 flu pandemic?

Largest study to date finds co-infection with MRSA increased death risk 8-fold; Flu vaccination urged Boston, Mass. -- During the 2009 H1N1 influenza pandemic, many previously healthy children ...

Tracking Swine Flu Vaccination Rates And Attitudes Via Twitter

A unique and innovative analysis of how social media can affect the spread of a disease has been designed and implemented by a scientist at Penn State University studying attitudes ...

Journal names discovery that HIV treatment can prevent spread 'breakthrough of the year'

Johns Hopkins researchers key part of team recognized for its scientific findings The finding of a team of researchers — including several members from Johns Hopkins ...

Sanofi (France) Taps David Meeker as New CEO of Genzyme Corporation

PARIS--(BUSINESS WIRE)--Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the appointment of David Meeker as Chief Executive Officer of Genzyme, a Sanofi company, effective November 1, 2011. ...

Abbott Laboratories's Absorb(TM) Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award

Abbott (NYSE: ABT) announced that the investigational ABSORB bioresorbable vascular scaffold (BVS) has been recognized as the winner of the Medical Devices category in the 2011 Wall Street Journal Technology ...

Warner C. Greene: focuses on the pathogenic interplay of the HIV-1 and HTLV-I human retroviruses with immune cells.

My laboratory focuses on the pathogenic interplay of the HIV-1 and HTLV-I human retroviruses with immune cells. Infection of human hosts with these retroviruses produces contrasting diseases within the CD4 subset of T lymphocytes, specifically the Acquired Immune Deficiency Syndrome (AIDS) with HIV-1 and the Adult T-cell Leukemia (ATL) with ...

TGen, Karmanos Lead $6M Melanoma Project

Sanford-Burnham Medical Research Institute and Pfizer Collaborate to Speed Drug Discovery

e2v aerospace and defense and Maxim Announce an Agreement to Extend the Product Life of Maxim Ceramic ICs

Syntaxin and Ipsen Ally to Develop Botulinum Toxin Therapeutics

BioAmber and LANXESS Partner for Renewable, Phthalate-free Plasticizers

Corgenix Partners with AXA Diagnostics on SkyLAB 752™ Automated Testing Platform

NHGRI Unveils New-Look Genome Sequencing Program; Plans $416M in Funding

NYU to Study Genetics of Obesity-Related Cancers

Researchers Get NHGRI Funding to Study Effects of Alzheimer's Risk Testing

Venture Firms Pump $18M into Fledgling Arteaus Therapeutics

Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics

Tetraphase Awarded Initial $6M by NIAID to Develop Antibiotic Against Biothreats